Wholesale Price Chemical Tirzepatide Peptide Synthesis GIP Agonist For Diabetes CAS 2023788-19-2

Tirzepatide Peptide Powder is an innovative pharmaceutical compound primarily used in research and drug development for the treatment of type 2 diabetes and obesity. It functions as a dual agonist for both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action enhances the body’s ability to regulate blood sugar levels, improve insulin sensitivity, and promote significant weight loss. The peptide powder form of Tirzepatide is typically intended for research purposes or pharmaceutical manufacturing, where it can be synthesized and formulated into an injectable drug.

Clinically, Tirzepatide has shown great promise in controlling blood glucose, reducing A1C levels, and aiding in weight management, making it a novel option for people with type 2 diabetes or those at risk of obesity-related complications. However, it is important to note that Tirzepatide Peptide Powder is not intended for direct human consumption unless formulated and prescribed by healthcare professionals. Its use in raw powder form is strictly for scientific research or medical trials, under controlled environments, to ensure safety, efficacy, and appropriate application in therapeutic settings. 

• Helps slow food leaving your stomach
• Helps prevent your liver from making too much sugar
• Helps the pancreas produce more insul when your blood sugar levels are high
• Can help control blood glucose
• Can reduce hyperglycemia, especially after meals
• Can reduce fasting insul and fasting glucose
• Can reduce hemoglobin A1c
• Can decrease appetite and caloric intake, while inhibiting weight gain
• Has been shown to lower triglyceride levels and oxidative stress from high LDL
• Has been shown to help induce weight loss in obese patients with higher dosing
• Helps decrease leptin and increase leptin sensitivity
• Can increase the conversion of white fat to brown fat